Risk of domperidone induced severe ventricular arrhythmia.

Scientific Reports
Byeong Geun SongPoong-Lyul Rhee

Abstract

There has been controversy over the cardiovascular safety of domperidone, attributable to the lack of a well-designed study as well as inconsistent results. This study aimed to examine the risk of severe domperidone-induced ventricular arrhythmia (VA), compared to mosapride, itopride, or non-use of all three prokinetics, in the general population. We conducted a population-based, self-controlled case series analysis. Enrolled subjects were individuals who were diagnosed with severe VA and were prescribed domperidone, mosapride, or itopride from 2003 to 2013 in the National Health Insurance Service-National Sample Cohort. The incidence rate ratio for severe VA was measured during exposure to prokinetics and compared with unexposed periods and itopride (no-proarrhythmic effect)-exposure periods, as control. A total of 2,817 subjects were included. Domperidone, mosapride, or itopride use was associated with increased risk of severe VA, compared with non-use (adjusted incidence rate ratios (IRR) of 1.342 (95% CI 1.096-1.642), 1.350 (95% CI 1.105-1.650), and 1.486 (95% CI 1.196-1.845), respectively). The risk of severe domperidone-induced VA was lower, compared to that of itopride [adjusted IRR of 0.548 (95% CI 0.345-0.870)]. Of the...Continue Reading

References

Aug 17, 1985·Lancet·R J OsborneJ Hamer
May 1, 1982·Lancet·R A JossR L Galeazzi
Dec 8, 1984·British Medical Journal·J B RoussakH Parry
May 20, 1999·The Annals of Pharmacotherapy·J A Barone
Jan 19, 2000·The American Journal of Gastroenterology·D L Dumitrascu, M Weinbeck
Jan 11, 2005·Pharmacology·Sonja Claassen, Bernd J Zünkler
Apr 2, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C SimardJ Turgeon
May 13, 2005·European Heart Journal·Sabine M J M StrausBruno H Ch Stricker
May 10, 2007·The American Journal of Gastroenterology·Savio C ReddymasuRichard W McCallum
Oct 12, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Charlotte van NoordMiriam C J M Sturkenboom
Sep 22, 2012·Obstetrics and Gynecology·David A Grimes, Kenneth F Schulz
Nov 29, 2012·Journal of Cardiovascular Pharmacology·Luc M Hondeghem
Jan 18, 2013·World Journal of Gastroenterology : WJG·Xuan HuangLi-Na Meng
Apr 2, 2015·The American Journal of the Medical Sciences·Arleen OrtizRichard W McCallum
Jun 23, 2015·Pharmacoepidemiology and Drug Safety·Hung-Lin Chen, Fei-Yuan Hsiao
Sep 10, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alejandro AranaKenneth J Rothman
Dec 10, 2015·Clinical Drug Investigation·Nattawut LeelakanokMarin L Schweizer
Jan 30, 2016·International Journal of Epidemiology·Juneyoung LeeKeeWhan Kim
Sep 14, 2016·BMJ : British Medical Journal·Irene PetersenHeather Whitaker
May 23, 2017·Gastroenterology·Michael F VaeziColin W Howden
Feb 15, 2018·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J R GiudicessiM Camilleri
Nov 6, 2018·United European Gastroenterology Journal·Serhat BorKivanc Yuksel
Feb 6, 2019·Journal of Clinical Gastroenterology·Justin FieldRon Schey

❮ Previous
Next ❯

Software Mentioned

gnm
R

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.